Modified Hemoglobin Solubility Test for Sickle Cell Zygosity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current hemoglobin solubility tests for sickle cell disease cannot accurately distinguish between sickle cell homozygotes and heterozygotes, often requiring complex confirmatory tests due to insolubility of hemoglobin S in phosphate buffer, leading to difficulties in early diagnosis and management.
Innovation Solution
A modified hemoglobin solubility test (MHST) involving a sample mixed with phosphate buffer, detergent, and reducing agent, followed by centrifugation and colorimetric analysis using a color chart or spectrophotometry, to differentiate between normal, heterozygous sickle cell, and homozygous sickle cell blood samples, and distinguish from thalassemia.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If the classic hemoglobin solubility test is used, then hemoglobin S can be detected, but the test cannot accurately distinguish between sickle cell homozygotes and heterozygotes
Solution Approach 1:
The patent modifies the classic solubility test by changing the chemical parameters of the test environment. Specifically, it uses a phosphate buffer at a controlled pH level and incorporates a reducing agent to alter the hemoglobin's solubility characteristics. This parameter modification enables the test to differentiate between homozygotes and heterozygotes based on varying degrees of insolubility, resolving the ambiguity of the classic test without requiring complex additional equipment.
Solution Approach 2:
The patent employs colorimetric analysis to detect and quantify hemoglobin S presence. By measuring color changes or turbidity in the test solution, the system can distinguish between different genotypes. The degree of color change or turbidity correlates with the amount of insoluble hemoglobin S, providing a visual and measurable differentiation between homozygous and heterozygous samples without requiring complex instrumentation.
2Reliability
If the classic solubility test is used, then sickle cell disease can be detected, but complex confirmatory tests are required
Solution Approach 1:
By optimizing the phosphate buffer concentration and pH parameters, along with adding a reducing agent, the test achieves sufficient diagnostic accuracy to eliminate the need for complex confirmatory tests. The modified parameters create conditions where the solubility differences between genotypes are pronounced enough for reliable differentiation, making the single test both diagnostic and confirmatory.
Solution Approach 2:
The patent replaces complex mechanical or multi-step confirmatory testing procedures with a simplified colorimetric measurement system. Instead of requiring multiple separate tests or complex instrumentation, the system uses optical measurement (color/turbidity detection) to provide both initial detection and confirmation in a single integrated test, thereby reducing overall testing complexity while maintaining reliability.
3Loss of time
If early diagnosis is achieved, then management can be started early, but the test must be simple and rapid
Solution Approach 1:
The patent modifies the test parameters to enable rapid results while maintaining accuracy. By using a phosphate buffer system with optimized pH and concentration, along with a reducing agent, the test achieves clear differentiation between genotypes quickly. The chemical reactions occur rapidly under these conditions, allowing early diagnosis without sacrificing precision, thus meeting both speed and accuracy requirements for early intervention.
Solution Approach 2:
The colorimetric method provides rapid visual or instrumented detection of hemoglobin S presence and quantity. The color change or turbidity development occurs quickly under the modified test conditions, enabling rapid differentiation between homozygotes, heterozygotes, and normal individuals. This rapid color-based detection allows for quick diagnosis and immediate initiation of management without requiring lengthy complex procedures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The MHST effectively differentiates between normal, heterozygous, and homozygous sickle cell blood samples with high accuracy, reducing the need for complex confirmatory tests and aiding in early diagnosis and management of sickle cell disease.
Implementation Method 1
A reducing agent, usually sodium hydrosulfite, is present in order to reduce the hemoglobin to the deoxygenated form, thereby altering its quaternary conformation and resultant solubility characteristics.
Implementation Method 2
The classic hemoglobin solubility testing in which sickle cell patients are identified is based on solubility differences between the normal hemoglobins A, A2, and F and hemoglobin S. Hgb S results from the expression of a point mutation in the 6th position of the beta globin chain causing the amino acid glutamic acid to be replaced with valine.
Implementation Method 3
subjecting the first solution to centrifugation to form a second solution and a supernatant
Implementation Method 4
taking a color reading of the supernatant and second solution; optionally filtering the second solution to form a filtrate and a precipitate, and optionally measuring the amount of the precipitate and the absorbance of the filtrate
Data Source
AI summary
The present invention provides a method for determining sickle-cell zygosity in a subject. The method involves forming a first solution which includes a sample from the subject, a phosphate buffer, a detergent, and a reducing agent and subjecting the first solution to centrifugation to form a second solution and a supernatant; and taking a color reading of the supernatant and of the second solution; optionally filtering the second solution to form a filtrate and a precipitate, and optionally measuring the amount of the precipitation and the absorbance of the filtrate or taking a color reading of the filtrate.